Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears …Business Wire (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on th…
Spectrum Pharmaceuticals and Allos Therapeutics Announce That FTC Clears …EON: Enhanced Online News (press release)The ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN …
ALLOS THERAPEUTICS, INC. : Spectrum Pharmaceuticals and Allos …4-tradersThe ZEVALIN therapeutic regimen consists of two components: rituximab, and Yttrium-90 (Y-90) radiolabeled ZEVALIN for therapy. ZEVALIN builds on the combined effect of a targeted…
Non-Hodgkin's lymphoma and chronic lymphocytic leukaemiaPharmacy EuropeTreanda is approved in patients with chronic lymphocytic leukaemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lym…
LUNDBECK : receives approval from Health Canada for Treanda …4-tradersTreanda is approved in patients with chronic lymphocytic leukemia (CLL) who have received no prior treatment and in patients with relapsed indolent B-cell non-Hodgkin's lymphom…
Rituximab and new regimens for indolent lymphoma: a brief update from 2012 …7thSpace Interactive (press release)Indolent lymphoma (IL), the second most common lymphoma, remains incurable with chemotherapy alone. While R-CHOP (rituximab, cyclophospham…
No single strategy best for stage I follicular lymphomaCuretoday.com (press release)In the rigorously staged group, patients treated with either rituximab/chemotherapy or systemic chemo plus radiation had significantly better progression-free survival …
Clinical Oncology NewsBendamustine Impressive For LymphomasClinical Oncology NewsChicago—The combination of bendamustine and rituximab (B-R) is superior to CHOP (cyclophosphamide, hydroxydaunorubicin, vincristine and prednisone) plus rituximab (CHOP-…
Biovest Conducts End of Phase III Review with FDA of BiovaxID? as …4-tradersThis includes rituximab which when used as a consolidation agent (rituximab maintenance) is generally administered on a bi-monthly dosing schedule over several years resultin…
Biologics treat blood vessel diseaseDaytona Beach News-JournalWith the diagnosis of Wegener's granulomatosis, Mr. Jones was successfully treated with a Rituximab (Rituxan) IV infusion — a biologic agent — and corticosteroids. In 1936 in Breslau, …